These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8574959)

  • 21. An approach to HIV gene therapy by transduction of multifunctional retroviral vectors in primary human T lymphocytes.
    Turchetto L; Benati C; Mattei S; Vicenzi E; Rossi C; Siccardi A; Poli G; Bordignon C
    J Biol Regul Homeost Agents; 1997; 11(1-2):79-81. PubMed ID: 9418169
    [No Abstract]   [Full Text] [Related]  

  • 22. A little learning is a dangerous thing; especially for a cytotoxic T-lymphocyte.
    Griffiths PD
    Rev Med Virol; 2003; 13(5):275-6. PubMed ID: 12931338
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting HIV reservoirs and reconstituting the immune system. Second annual meeting Research Institute for Genetic and Human Therapy April 18-19, 1999 Washington, DC.
    Lori F; Lisziewicz J
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1597-617. PubMed ID: 10606083
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of CD8+ T-cell cytotoxicity in HIV-1 infection.
    Saeidi A; Buggert M; Che KF; Kong YY; Velu V; Larsson M; Shankar EM
    Cell Immunol; 2015; 298(1-2):126-33. PubMed ID: 26520669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Destructive networks in AIDS.
    Kennedy JR
    Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune control.
    Fornataro K; Jefferys R
    Body Posit; 1999 Mar; 12(3):9-12. PubMed ID: 11366299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs.
    Levine B; Leskowitz R; Davis M
    Expert Opin Biol Ther; 2015 Jun; 15(6):831-43. PubMed ID: 25947115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy approaches to HIV-infection: immunological strategies: use of T bodies and universal receptors to redirect cytolytic T-cells.
    Bitton N; Gorochov G; Debre P; Eshhar Z
    Front Biosci; 1999 Apr; 4():D386-93. PubMed ID: 10099136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells.
    Ye JF; Lin YQ; Yu XH; Liu MY; Li Y
    Int Immunopharmacol; 2016 Sep; 38():460-7. PubMed ID: 27380620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can immune systems be trained to fight HIV?
    Balter M
    Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544
    [No Abstract]   [Full Text] [Related]  

  • 33. Active immune therapy for the treatment of HIV infections.
    Letvin NL; Chen ZW; Yamamoto H; Watanabe M
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1499. PubMed ID: 1466989
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity.
    Torpey D; Huang XL; Armstrong J; Ho M; Whiteside T; McMahon D; Pazin G; Heberman R; Gupta P; Tripoli C
    Clin Immunol Immunopathol; 1993 Sep; 68(3):263-72. PubMed ID: 8370181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-specific CD8+ T-cell immune responses and viral replication.
    Buseyne F; Rivière Y
    AIDS; 1993 Nov; 7 Suppl 2():S81-5. PubMed ID: 7909230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-unrestricted killing of HIV-1 gag protein-expressing CD4 T cells by gag-specific CD8 cytotoxic T cells.
    Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
    AIDS; 1999 Aug; 13(12):1583-4. PubMed ID: 10465085
    [No Abstract]   [Full Text] [Related]  

  • 38. Chimeric immune receptor T cells bypass class I requirements and recognize multiple cell types relevant in HIV-1 infection.
    Severino ME; Sarkis PT; Walker BD; Yang OO
    Virology; 2003 Feb; 306(2):371-5. PubMed ID: 12642109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
    Sun L; Guo H; Jiang R; Lu L; Liu T; He X
    Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of killing of HIV-infected T cells and disease progression.
    Huynen MA; Neumann AU
    Science; 1996 Jun; 272(5270):1962. PubMed ID: 8658174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.